Product Images Tizanidine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Tizanidine NDC 53002-1437 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

molecular structure - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01

molecular structure - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01

Figure-1 - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02

Figure-1 - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02

Figure 3 - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03

Figure 3 - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03

Figure 4 - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04

Figure 4 - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04

This text describes a study with a mean dose of 26.8 mg and the improvement in Ashworth Score. The study was carried out in several weeks, with observations made at the end of each week, culminating in the Endpoint. The study observed the changes in the Ashworth Score over time and could therefore be used to evaluate the effectiveness of a treatment.*

logo - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05

logo - ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05

Label Image - lbl530021437

Label Image - lbl530021437

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.